Tislelizumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5004
Add to Compare
$306.00

Tislelizumab Biosimilar - Research Grade

Product Benefits:

ichorbio's Tislelizumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. Click here to view ichorbio’s complete list of anti-PD-1 antibodies and biosimilars.

Size:

ichorbio's Tislelizumab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our Tislelizumab biosimilar - please contact us for pricing.

Target:

PD-1

Isotype:

IgG4 kappa

Other Names:

Programmed cell death protein 1, Pdcd1, CD279

Host:

CHO cells

Species Reactivity:

Human

Specificity:

Detects human PD-1.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background:

Tislelizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149 kDa.

Concentration:

1.0 - 5.0 mg/ml

Formulation:

Sterile, preservative-free, clear to milky white colorless to slightly yellow solution, containing L-histidine , polysorbate 80 and sucrose. pH set to 5.5. BSA and Azide free.

Purity:

>95% by SDS-PAGE and HPLC

Endotoxin:

≤ 0.75 EU/mg as determined by the LAL method

Storage:

Tislelizumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.

Applications:

Functional Assays

Application Notes:

Each investigator should determine their own optimal working dilution for specific applications.

Isotype Control:

Bulk Human IgG4 Isotype Control (IB4) [ICH2257]

Use: ichorbio's Tislelizumab biosimilar is for research use only (RUO).
More Information
Concentration 9.48mg/ml
Isotype IgG4 kappa
Host CHO cells
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications Functional Assays
Storage Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles.
Endotoxin <1 EU/mg Determined by LAL gel clotting assay
Purity >95% by SDS-PAGE and HPLC
Formulation Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Tislelizumab.
Species Reactivity Human
Target PD-1
Shipping Conditions Blue ice
background Pembrolizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149 kDa.
Other names Programmed cell death protein 1, Pdcd1, CD279
UniProt Q15116
Buffer ICH3002
Sequence https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Tislelizumab Biosimilar - Research Grade
Your Rating
Back to Top